Anterios is a privately held, clinical-stage biopharmaceutical company
that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine.
Anterios has developed NDS, a proprietary platform technology that enables local, targeted delivery of botulinum toxin and other macromolecules across the skin without needles or other invasive treatments that can be destructive to the skin. NDS also enables the formulation of macromolecules as ready-to-use liquid injectable products.
In the future, Anterios plans to develop additional dermatology products to topically deliver active ingredients other than botulinum, as well as formulate additional injectable products that require deeper delivery. I
Company Details
- Founded
- -
- Address
- 60 East 42nd Street, New York,ny 10165,united States
- Phone
- 212-303-1683
- in****@****inc.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- anteriosinc.com
- Keywords
- Aliso Viejo.
- HQ
- New York, NY
Anterios Therapeutics Questions
Anterios Therapeutics's helpline number is 212-303-1683
Anterios Therapeutics's website is anteriosinc.com
Anterios Therapeutics's LinkedIn profile is https://www.linkedin.com/company/anterios-inc-
Anterios Therapeutics's industry is
Biotechnology Research
Anterios Therapeutics's top competitors are
Intrommune Therapeutics,
Invitro Cell Research, Llc,
Vwise, Inc.,
Mirimus,
Elevatebio,
Bluerock Therapeutics,
Wrs Therapeutics,
Lime Therapeutics,
Rumi Scientific,
Allovate Therapeutics.
Anterios Therapeutics's support email address is info@anteriosinc.com
Anterios Therapeutics's categories are Biotechnology Research
Anterios Therapeutics's founding year is 2002
